Phase II Study Investigating the Safety and Efficacy of Savolitinib and Durvalumab in Metastatic Papillary Renal Cancer (CALYPSO) Cancer is the second leading cause of death globally. However, by ...

MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced performance data for its blood-based colorectal cancer ...

Circulating tumor DNA (ctDNA) analysis and advanced tumor profiling in GI cancers highlight opportunities for recurrence monitoring and targeted therapy selection Modeling analyses and real-world ...

Please provide your email address to receive an email when new articles are posted on . Surveillance led to detection of smaller tumors among patients at high risk for pancreatic cancer. Individuals ...

Please provide your email address to receive an email when new articles are posted on . Over 80% of people at high risk for lung cancer were unaware of screening or had not discussed it with a doctor.

The US Preventive Services Task Force (USPSTF) has once again concluded that there is insufficient evidence to determine the balance between the benefits vs the harms of clinicians screening ...

MELVILLE, N.Y.--(BUSINESS WIRE)--Accio Data, the background screening industry’s leading enterprise platform provider, and Intellicheck, Inc. (Nasdaq: IDN), an industry-leading identity company ...

Companies that handle massive amounts of user data are often the least careful with it. Last year, the National Public Data breach exposed 2.7 billion records. The company’s entire business model was ...

Having trouble finding a landlord willing to rent to you? It may be thanks to the tenant-screening companies that pull renters’ credit history, criminal records, eviction filings and more to present ...